Skip to main content
Premium Trial:

Request an Annual Quote

Part of the Process

At the American Chemical Society Careers blog, John Borchardt says that "working effectively with patent attorneys can both increase the number of patents you are awarded and improve their quality." To initiate an effective working relationship with patent attorneys, Borchardt suggests getting to know a bit more about their goals, and about the patenting process.

"Patent attorneys usually approach situations with a different mindset than researchers do," he says. While researchers may consider the technicalities of an invention, patent attorneys are typically more interested in "how your competitors will try to legally get around your patent and develop something very similar," Borchardt says.

It's important that researchers understand the patenting process, Borchardt adds. For their part, patent attorneys "may ask questions leading to the inventor to perform additional experiments to broaden the scope of the invention and to support the patent claims that define the invention," he says — that's all part of the process.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.